The present study has taken advantage of publicly available cell type specific mRNA expression databases in order to identify potential genes participating in the development of retinal AII amacrine cells. We profile two such genes, Delta/Notch-like EGF repeat containing (Dner) and nuclear factor I/A (Nfia), that are each heavily expressed in AII amacrine cells in the mature mouse retina, and which conjointly identify this retinal cell population in its entirety when using antibodies to DNER and NFIA. DNER is present on the plasma membrane, while NFIA is confined to the nucleus, consistent with known functions of each of these two proteins. DNER also identifies some other subsets of retinal ganglion and amacrine cell types, along with horizontal cells, while 
. The present study has sought to identify other novel proteins that are expressed by developing and mature AII amacrine cells, by taking advantage of recent advances in molecular profiling, particularly in single cell RNA-sequencing, that have begun to differentiate the subtleties that exist between different cell types through their transcriptome-wide molecular signatures (Kay, Chu, & Sanes, 2012; Siegert et al., 2012; Macosko et al., 2015; Shekhar et al., 2016) . These gene expression profiles offer a comprehensive look into the proteins that must be critical for the development and function of specific cell types in the retina, including the AII amacrine cell.
In this study, we have used recently published expression profiles of retinal cell types to identify genes that may have roles critical for the development of AII amacrine cells. We found two genes, Delta/Notchlike EGF repeat containing (Dner) and nuclear factor I/A (Nfia), that are highly expressed in these cells, both in development and adulthood. We subsequently validated the expression of their protein products using immunofluorescent techniques, and determined that probing for both proteins conjointly is a reliable method for identifying the population of AII amacrine cells. As both genes are known to play a role in neural development outside the retina, they are prime candidates for understanding the mechanisms that underlie the development of the AII amacrine cell.
| M A TE RI A L S A ND M E TH ODS

| Candidate gene search
Three publicly available gene expression datasets were analyzed to identify novel proteins expressed by AII amacrine cells (NCBI GEO series GSE63473, GSE81904, and GSE35077; www.ncbi.nlm.nih.gov/geo/; RRID:SCR_007303). Two different single cell RNA-seq experiments (one using dissociated cells from whole retinas and another analyzing single cells after enriching for bipolar cells) were combined to assess the levels of gene expression within different cell types of the retina, including the AII amacrine cells (Macosko et al., 2015; Shekhar et al., 2016) . Cells were organized into cell clusters (as defined by the original authors) and, for every gene, the total number of transcripts sequenced across all cells within a cluster was tabulated; from these data, the average number of transcripts expressed per cell was calculated. Genes that were highly expressed in AII amacrine cells were then compared against all other cell populations to determine the specificity of expression. The same approach was used to assess the transcriptome of AII amacrine cells at postnatal day 7 (day of birth 5 P1), using microarray data derived from purified populations of retinal cell types (Kay et al., 2012) . For gene transcripts identified by multiple microarray probes, the maximum expression value across the probes was used. When analyzing the transcriptome within AII amacrine cells, gene expression was normalized to the highest expressed gene; when comparing across cell types, gene expression was normalized to that within the AII amacrine cell population.
| Tissue preparation
Retinas were collected from adult (>P30) or developing (P1, P5, P10) C57Bl/6J (B6/J; RRID:IMSR_JAX:000664) mice that were originally obtained from The Jackson Laboratories (Bar Harbor, ME) and maintained at UCSB. Adult mice were given a lethal injection of sodium pentobarbital (>120mg/kg, i.p.; Euthasol, #710101; Vibrac, Fort Worth, TX), and, once deeply anesthetized, intracardially perfused with approximately 2 ml of 0.9% saline via syringe, followed by approximately 50 ml of 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB, pH 7.3) administered over 15 mins via gravity, all as recently described in greater detail (Keeley, Whitney, & Reese, 2017) . Young postnatal mice were given a similar injection of sodium pentobarbital, but once deeply anesthetized, eyes were removed from the orbit and directly immersed in 4% paraformaldehyde for a total of 30 mins. Whole retinas were then dissected free from the eyes, and four relieving cuts were made to allow the retinas to lie flat. Some of these retinal wholemounts were embedded in 5% agarose in 0.1M PB and then sectioned radially into 150 mm sections on a Vibratome (The Vibratome Company, St Louis, MO).
| Antibodies
We used two antibodies in this study, the staining patterns of which had never been characterized in the mouse retina. The antibody used to detect DNER (1:500; #AF2254; R&D Systems, Minneapolis, MN; RRID: AB_355202) was a goat polyclonal IgG raised against recombinant mouse DNER (aa26-637) derived from the mouse myeloma cell line NS0, which was confirmed by the manufacturer to detect mouse DNER in ELISA and Western blot assays, as well as label Purkinje cells of the mouse cerebellum, as expected. This antibody also labeled cells in the chick cochlea in a manner that was consistent with RNA expression data (Kowalik & Hudspeth, 2011) . The antibody used to detect NFIA (1:500; #HPA006111; Sigma, St. Louis, MO; RRID:AB_1854422) was a rabbit polyclonal IgG raised against recombinant human NFIA (aa278-378). It was developed in conjunction with the Human Protein Atlas project (www.proteinatlas. org), which validated that the staining pattern of this antibody in human tissues matched known expression data and subcellular localization.
While this antibody was raised against the human NFIA protein, the immunogen used is 98% homologous with the mouse NFIA protein, suggesting a high likelihood that this antibody would be useful in identifying NFIA in mouse tissue. Indeed, immunostaining of the mouse cortex revealed nuclear staining consistent with known expression patterns (Nagao, Ogata, Sawada, & Gotoh, 2016) . Serial dilutions of each antibody were initially run with adult retinal sections to determine optimal concentrations for immunofluorescence. Additionally, two controls were performed to determine their specificity: first, each antibody was incubated with an eight-fold excess of its immunogenic peptide (Recombinant Mouse DNER Fc Chimera, #2254-DN-050, R&D Systems; PrEST Antigen NFIA, #APrEST70957, Sigma) at room temperature for 2 hr prior to use; second, PBS-TX was substituted for the primary antibody itself. Both controls yielded no trace of labeling on these sections (Figure 1 ).
All other primary antibodies used in this study detect proteins which have been well characterized in the mouse retina, and immunofluorescence labeling using these antibodies was consistent with the staining patterns initially reported for these antigens. The details for each of these antibodies are listed in Table 1 . Evidence for the specificity of these antibodies to their specific targets in the mouse retina is as follows. (a) The antibody to Prox1 has been used previously to label the nuclei of AII amacrine cells (Keeley et al., 2014; P erez de Sevilla M€ uller, Azar, de Los Santos, & Brecha, 2017) , consistent with the known localization of the protein in these cells (Dyer et al., 2003) .
Prox1 is also found in the nuclei of bipolar cells and horizontal cells (Dyer et al., 2003) , which are also labeled using this antibody. (b) The antibody to TH detects a single band on immunoblots between 50 and 65 kDa when using lysates from mouse brain (Millipore, #AB1542 datasheet) and PC12 cells (Haycock & Waymire, 1982) . This antibody labels the somata and processes of the dopaminergic amacrine cells using immunofluorescence, as expected (Versaux-Botteri, NguyenLegros, Vigny, & Raoux, 1984) . (c) The antibody to calbindin recognizes the calbindin D-28K protein on immunoblots when using lysates from rat hippocampus (Millipore, #PC253L datasheet), and we have used this antibody previously to label the somata and processes of horizontal cells (Raven, Stagg, Nassar, & Reese, 2005) ; additionally, it labels amacrine cells and some ganglion cells. This is consistent with the originally described staining pattern (Pochet et al., 1991) . tern that is consistent with that originally observed (Pinto et al., 1994) . a 60 kDa protein on immunoblots when using lysates from mouse cerebellum, which has been confirmed to be synaptotagmin 2 via mass spectrometry (Fox & Sanes, 2007) . This antibody labels synaptic puncta in the outer plexiform layer (OPL), as well as the membranes of type 2 and type 6 bipolar cells, the former being much more strongly labeled than the latter (Fox & Sanes, 2007) . (g) The antibody to GS detects a single 45 kDa protein on immunoblots using rat cerebrum lysate, and labels astrocytes in the rat cerebrum (BD Biosciences, #610517 datasheet). This antibody labels the processes of M€ uller glia in the retina, as expected (Linser, Sorrentino, & Moscona, 1984) . (h) The antibody to GFAP reacts specifically with GFAP protein in immunoblotting assays and labels astrocytes, Bergmann glia, and chondrocytes of elastic cartilage in immunohistochemical staining (Sigma, #C9205 datasheet). Consistent with the reported expression of GFAP in mature mouse retina (Bromberg & Schachner, 1978) , this antibody labels astrocytic processes in the nerve fiber layer. 
| Immunofluorescence
The following protocol was used to label retinal wholemounts or sections with antibodies: tissue was first incubated in 5% Normal Donkey Serum (#D9663; Sigma, St Louis, MO) in phosphate buffered saline with 1% TritonX-100 (PBS-TX) for a total of 3 hr.
The samples were then rinsed with PBS three times for 10 mins each, then transferred to a solution of primary antibodies diluted in PBS-TX and incubated for three nights. After another set of three rinses in PBS, the tissue was incubated in a solution of secondary antibodies conjugated to fluorescent dyes (Table 2) in PBS-TX overnight. For some sections, Hoechst 33342 (1:1,000; #H3570; Thermo Fisher Scientific, Waltham, MA) was added with secondary antibodies to label cell nuclei. After a final three rinses in PBS, wholemount retinas or sections were mounted on glass slides with Fluoro-Gel (#17985-10; EMS, Hatfield, PA). All incubation steps were performed with slight agitation, using an orbital shaker, and at 48C. 3D image stacks were captured using an Olympus Fluoview1000 laser scanning confocal microscope, and all micrographs presented here are maximum projection images (between 1 and 3 mm thick) derived from these stacks, with a few exceptions that are noted in the figure legends. 3.2 | DNER is localized to the somatic membrane of cells in the inner nuclear layer and ganglion cell layer, and is found throughout the plexiform layers
As shown in Figure 3a , antibodies to DNER revealed strong punctate labeling throughout both the IPL and OPL, and many, but not all, cell bodies were labeled in the GCL and INL. We did not detect any labeling in the outer nuclear layer (ONL). This pattern of labeling appears to be consistent with the expression profile analysis, with broad expression in amacrine, ganglion, and horizontal cells, and a lack of expression in bipolar and photoreceptor cells (Figure 2b) . Additionally, the labeling appeared to be membranous, as expected of a transmembrane protein;
indeed, previous studies overexpressing DNER in cell culture found the protein in the plasma membrane of the soma and dendritic compartments, as well as in the membrane of cytoplasmic endosomes (Eiraku, Hirata, Takeshima, Hirano, & Kengaku, 2002) . Figure 5b ) is present at all locations across the retina, in densities that appear similar to the population of Prox11 AII amacrine cells (Keeley et al., 2014) . Their local distribution (e.g., Figure 5b ) also mimics the random somal patterning shown to be present in the Prox11 amacrine cell population in the mouse retina . Because our Prox1 antibody was raised in the same species to that used for generating the NFIA antibody, we could depth. The total population of AII amacrine cells, labeled with Prox1 antibodies, in the B6/J strain of mouse has been previously estimated to be 69,223 6 1,566 (mean 6 SEM) cells per retina (Figure 5c ; Keeley et al., 2014) . Our estimated total number of DNER1/NFIA1 double-labeled cells, conducted in this very strain, was 69,998 6 1,572 cells per retina (Figure 5c ). We note that the variance is both low, as well as comparable, between the labeling methods, the coefficient of variation being 0.06 in both cases. We therefore conclude that this double-labeling strategy is effective in unambiguously identifying AII amacrine cells.
3.5 | DNER and NFIA are expressed in the early postnatal retina, suggesting a developmental role for both proteins
As predicted by the transcriptome analysis (e.g., Figure 
| D ISC USSION
In this study, we used publicly available expression datasets of individual retinal cell types (Kay et al., 2012; Macosko et al., 2015; Shekhar et al., 2016) to identify two genes, Dner and Nfia, that are highly expressed in AII amacrine cells. We verified that the proteins are detectable in these cells, and while each is not exclusive to the AII amacrine cells, labelling for both proteins allows for accurate identification of this entire population. In addition, these genes are expressed in early postnatal development, being upregulated in AII amacrine cells during DNER is expressed in various brain regions, including the developing and mature cortex, cerebellum, and hippocampus. Initial reports indicated that the protein is localized to the plasma membrane of the dendritic compartment, but is excluded from the axonal compartment (Eiraku et al., 2002) , while cell culture experiments confirmed that DNER expression on the plasma membrane plays a promotive role in neuritogenesis (Fukazawa et al., 2008) . Knockout mice showed impairments in motor function considered a consequence of abnormal cerebellar development, where a delay in the morphogenesis of this structure is thought to disrupt the refinement of Purkinje cell connectivity in adulthood (Tohgo et al., 2006; Saito & Takeshima, 2006) (Marc et al., 2014) . We have shown that DNER is accumulated at the neck of the AII amacrine cells, and that this pattern is present during early postnatal development, suggesting a potential role in the differentiation of AII amacrine cell morphology and connectivity.
The function of the zebrafish Dner protein has been characterized as well, shown to induce the differentiation of neurons and glia at the expense of proliferation when overexpressed in neural progenitor cells, and these effects were determined to work through both Notchdependent and Notch-independent mechanisms (Hsieh et al., 2013) .
Notch signaling is involved in cell fate decisions in the retina (Livesey & Cepko, 2001) , particularly in the creation of M€ uller glia (Vetter & Moore, 2001 ). As we found no evidence of DNER expression in the neuroblastic layer of the postnatal retina, however, this seems an unlikely function for it in the developing mouse retina. It should be noted as well that a recent report has indicated that this protein is not a direct ligand of Notch, as previously assumed (Greene et al., 2016) , complicating the interpretation of how DNER might play a role in these processes.
NFIA is also widely expressed throughout the developing nervous system. It is one of four NFI transcription factors, all of which display unique, but overlapping, patterns of expression during development and in the adult mouse (Gronostajski, 2000) . All of these transcription factors are found in the brain, and play a critical role in neural development, as mice deficient in these proteins exhibit many behavioral dysfunctions (Mason, Piper, Gronostajski, & Richards, 2009) . One well studied role for NFIA, in particular, is in gliogenesis, as knockout mice
show an absence of important glial structures at the midline leading to a failure of the corpus callosum to form (das Neves et al., 1999; Shu, Butz, Plachez, Gronostajski, & Richards, 2003) . As a key player in the differentiation of glial populations, NFIA interacts with many other known transcription factors that participate in this process, such as Hes1, Lhx2, Sox9, and Sox10, as well as influencing the Notch pathway in progenitor cells (Piper et al., 2010; Subramanian et al., 2011; Kang et al., 2012; Glasgow et al., 2014) . It is interesting to note that many of these genes are also active in the developing retina (de Melo, Clark, & Blackshaw, 2016) , and that we have found NFIA to be expressed in both M€ uller glia and astrocytes in the developing and mature retina, NFIA does not just affect glial populations, however, as it appears to play a role in neuronal development as well (Plachez et al., 2008) .
NFIA is expressed by cerebellar granule cells and is involved in their migration, dendritic arborization, and axon guidance (Wang et al., 2007) . Abnormalities in these processes were observed in knockout mice, as was a decrease in the expression of several cell adhesion molecules, two of which were confirmed to have NFI binding sites upstream of their promoters, suggesting direct regulation of these genes by NFIA (Wang et al., 2007) . It is possible that similar mechanisms may be at play in the AII amacrine cell population, as these cells express several cell adhesion molecules in development, such as Cadherin1, EphrinA5, and EphA7 (Kay et al., 2012) . The Dner gene, itself coding for an adhesion molecule, contains a NFI binding motif in the first intron, hinting at a possible regulation by NFIA. Future studies that target these genes in the retina, including knockout and misexpression experiments, should help elucidate the role of these two molecules in the development of the retina, and in the population of AII amacrine cells themselves.
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